bpc 157 hashimoto's intranasal bpc-157 nasal spray studies TB-500 Benefits Nose-to-Brain Delivery of Therapeutic Peptides – BPC-157: The Promise and Perils

Without a batch Certificate of Analysis, you are trusting a label nothing more

We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials

Both methods have their perks, but we need more research to know which one wins the prize

Each batch is synthesized in the United States and tested by HPLC and mass spectrometry

Beginners typically start with 0.5-1mg administered subcutaneously 3-5 times per week

Usage under expert guidance is crucial